Balaji Amines Ltd. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2013
January 29, 2014 at 08:08 am
Share
Balaji Amines Ltd. reported unaudited earnings results for the third quarter and nine months ended December 31, 2013. For the quarter, the company's net sales from operations were INR 1,375.136 million compared to INR 1,077.462 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 149.365 million compared to INR 133.456 million a year ago. Profit from ordinary activities before tax was INR 67.765 million compared to INR 76.374 million a year ago. Net profit for the period was INR 41.990 million or INR 1.30 per basic and diluted share after extraordinary items compared to INR 71.934 million or INR 2.22 per basic and diluted share after extraordinary items a year ago.
For the nine months, the company's total income from operations was INR 4,386.315 million against INR 3,703.155 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 579.445 million against INR 531.045 million a year ago. Profit from ordinary activities before tax was INR 367.219 million against INR 369.213 million a year ago. Net profit for the period was INR 244.444 million or INR 7.54 per basic and diluted share after extraordinary items against INR 254.511 million or INR 7.86 per basic and diluted share after extraordinary items a year ago.
Balaji Amines Limited is an India-based company, which is engaged in the business of manufacturing of specialty chemicals, aliphatic amines and derivatives. The Companyâs segments include Amines & Specialty Chemicals and Hotel Division. It also owns a five-star Hotel in Solapur, Maharashtra. Its products include amines, derivatives, specialty chemicals and pharma excipients. Its amine products include MONOMETHYLAMINE (MMA), DIMETHYLAMINE (DMA), TRIMETHYLAMINE and others. Its specialty chemical products include N-Methyl Pyrrolidone (NMP), Morpholine, 2-PYRROLIDONE (2-P), N-ETHYL-2-PYRROLIDONE, GAMMA-BUTYROLACTONE, ACETONITRILE (ACN) and others. Its derivatives products include Di-Methyl Acetamide (DMAC); Di-Methyl Amine Hydrochloride (DMA HCL); Tri-Methyl Amine Hydrochloride (TMA HCL); Di-Ethyl Amine Hydrochloride (DEA HCL), and others. Its pharma excipients products include POLY VINYL PYRROLIDONE(PVP-30) IP/BP/JP GRADE and POLY VINYL PYRROLIDONE(PVP-30)-TECHNICAL GRADE.